A groundbreaking national study has revealed that over one-third of US adults have used hemp-derived cannabinoids, highlighting a massive shift in how Americans manage their health and leisure. While products like CBD are overwhelmingly used for medical relief, newcomers like delta-8 THC are primarily being sought out for recreational “highs” similar to traditional cannabis.+4
The research, published in the Journal of Cannabis Research, surveyed 1,523 adults across the United States to map the prevalence of various compounds following the 2018 Farm Bill. Researchers found that CBD remains the most popular, with 35.2% of the population reporting lifetime use. Other emerging cannabinoids, including delta-8 THC (7.7%), CBN (4.5%), CBG (1.3%), and HHC (1.5%), have also established a significant foothold in the market.+4
The motivations behind use vary sharply by product. For CBD, nearly 72% of users reported medical reasons, specifically citing relief for anxiety, chronic pain, and joint issues (arthralgia). Conversely, 76% of delta-8 THC usersreported using it for recreation, often as a legal alternative to delta-9 THC in states where marijuana remains restricted.+4
Despite the popularity, health officials are raising red flags regarding the lack of regulation. The study noted that many users are self-treating for conditions like insomnia and depression based on manufacturer claims that have not been verified by the FDA. Furthermore, emerging synthetic compounds like HHC have been linked to rare but serious adverse events, including psychosis.+4
As the “hemp-derived” market continues to outpace federal oversight, experts suggest that better consumer education and stricter labeling standards are essential to ensure safety.
This topic is covered in depth in our Complete Science-Based Guide to CBD.